FDA label dbdde3f1-9364-47b6-aac0-d53b43d0a177

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

SPL set ID
33538851-4e77-4c28-a92f-e64163619597
SPL ID
dbdde3f1-9364-47b6-aac0-d53b43d0a177
Version
1
Effective date
2012-03-28
Source export date
2026-10-12
Source partition
13
Source file
https://download.open.fda.gov/drug/label/drug-label-0013-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-10-12/b8dac220ac9fc8ffb4d86c6e00ece30169fc4575ca0cc92e5c9ce1a524fb0249/drug-label-0013-of-0014.json.zip
Source manifest SHA-256
7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run
20261013T011858Z
Imported at
2026-10-13 03:03:00

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For oral use only. When using this product avoid contact with eyes. In case of accidental contact with eyes, flush with water and immediately seek professional help. Ask a doctor before use if you are taking minocycline, doxycycline, tetracycline or are on coumadin therapy, zinc treatment may inhibit the absorption of these medicines. Stop use and ask your healthcare practitioner if symptoms persist beyond 7 days. COLD-EEZE ® Oral Spray is formulated to reduce the duration of common cold symptoms and may be insufficient treatment for Influenza or Allergies. If pregnant or breast-feeding, ask a healthcare practitioner before use. Keep out of reach of children.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.